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han MY, Mahaffey KW, Sun LJ, Pieper KS, White HD, Aylward PE, Ferguson JJ, Califf RM, Roe
T. Prevalence, Predictors, and Impact of Conservative Medical Management for Patients With
on-ST-Segment Elevation Acute Coronary Syndromes Who Have Angiographically Documented
ignificant Coronary Disease. J Am Coll Cardiol Intv 2008;1:369-78.
his article contained the following errors:
. In the abbreviations section on page 370, “GRACE  Global Registry of Acute Coronary Events
score” should read “GRACE  Global Registry of Acute Coronary Events” without the word score.
. On page 372, Table 1, the median age of the MM group reads “15.3 (9.5, 21.0).” It should read “69
(62, 75).” The corrected table is printed below.
. On page 373, the following sentence currently reads “The early risk of death from CABG was seen in
the first 90 days, but, after that period, the risk in the medical cohort increased at a greater rate and the
2 curves cross” it should read “The early risk of death from CABG was seen in the first 90 days, but,
after that period, the risk in the medical cohort increased at a greater rate and the 2 curves crossed.”
Table 1. Baseline Characteristics
Characteristic
MM
(n  2,633)
PCI
(n  4,294)
CABG
(n  1,298) p Value
Median age, yrs 69 (62, 75) 67 (60, 74) 67 (61, 74) 0.001
Female gender, % 32.8 31.7 25.9 0.001
Race, % 0.001
White 83.6 87.4 85.5
Black 7.3 5.4 6.3
Asian 1.9 0.7 0.8
Hispanic 4.6 4.7 5.5
U.S. enrollment, % 44.4 59.5 79.1 0.001
Hypertension, % 70.9 65.8 70.3 0.001
Diabetes, % 33.3 26.2 33.2 0.001
Smoking, % 35.6 34.2 36.1 0.001
Hypercholesterolemia, % 61.8 59.4 60.0 0.144
Prior MI, % 34.2 25.9 23.4 0.001
Prior heart failure, % 12.2 6.5 6.8 0.001
History of stroke, % 6.1 3.8 5.2 0.001
History of PVD, % 11.9 8.7 9.1 0.001
Prior CABG, % 23.0 16.1 6.7 0.001
Prior PCI, % 22.5 21.6 15.2 0.001
Hours from symptom onset (quartiles 1 and 3) 15.3 (9.5, 21.0) 14.4 (8.1, 20.5) 14.3 (8.0, 20.4) 0.001
Killip class II–IV, % 14.8 8.9 13.1 0.001
Systolic BP, mm Hg 132 (118, 150) 130 (117, 146.0) 130 (117, 147) 0.033
Heart rate, beats/min 70 (62, 81) 70 (62, 80) 72 (64, 83) 0.001
Creatinine clearance, ml/min* 71.1 (53.6, 92.5) 79.2 (60.6, 101.8) 77.4 (57.8, .98.6) 0.001
ST-segment depression on ECG, % 57.5 53.0 59.6 0.001
Elevated cardiac enzymes, %† 64.4 70.2 69.9 0.001
Values in parentheses are 25th, 75th percentile. *Creatinine clearance calculated using the Cockroft-Gault formula; †troponin or creatine kinase-MB fraction above the upper
limit of normal.
BP  blood pressure; CABG  coronary artery bypass grafting; ECG  electrocardiogram; MI  myocardial infarction; MM  conservative medical management; PCI 
percutaneous coronary intervention; PVD peripheral vascular disease.
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Corrections
601. On page 376, Table 6, the hazard ratio and 95% confidence interval for death at 1 year for all patients under the Adjusted
HR 95% CI for MM vs. PCI (Model 2) and Adjusted for Baseline Characteristics In-Hospital Events Propensity
for MM headings (row 4, column 5) reads “1.32 (0.88–0.97).” It should read “1.32 (0.88–1.97)”. The corrected table is
printed below.
e apologize for these errors.
doi:10.1016/j.jcin.2008.03.019
rodie BR, Stuckey T, Downey W, Humphrey A, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B,
uffy P, Smith H, Edmunds J, Varanasi J, Simonton CA, for the STENT (Strategic Transcatheter Evaluation of New
herapies) Group. Outcomes and Complications With Off-Label Use of Drug-Eluting Stents Results From the
TENT (Strategic Transcatheter Evaluation of New Therapies) Group. J Am Coll Cardiol Intv 2008;1:1405–14.
n this article, there was an error in the right side of Figure 4B. A corrected Figure 4B is printed below. The authors
pologize for this error.
doi:10.1016/j.jcin.2008.06.005
Table 6. Post-Discharge Events*
Outcome
MM
(n  2,633)
PCI
(n  4,294)
Adjusted HR  95% CI for MM vs. PCI
(Model 2)
CABG
(n  1,298)
Adjusted HR  95% CI for MM vs. CABG
(Model 2)
Adjusted for Baseline
Characteristics 
In-Hospital Events
Adjusted for Baseline
Characteristics 
In-Hospital Events 
Propensity for MM
Adjusted for Baseline
Characteristics 
In-Hospital Events†
Adjusted for Baseline
Characteristics 
In-Hospital Events 
Propensity for MM
All patients
Death/MI at 6 months 11.7% 4.7% 2.01 (1.61–2.51) 1.99 (1.59–2.49) 4.9% 3.80 (2.65–5.47) 3.47 (2.40–5.02)
MI at 6 months 7.5% 3.3% 1.99 (1.52–2.60) 1.92 (1.46–2.52) 1.7% 6.65 (3.74–11.83) 6.27 (3.50–11.23)
Death at 1 yr 7.7% 3.6% 1.30 (0.87–1.95) 1.32 (0.88–1.97) 6.2% 1.77 (0.98–3.19) 1.83 (1.00–3.37)
Censored patients†
Death/MI at 6 months 8.0% 4.7% 1.43 (1.10–1.86) 1.38 (1.06–1.80) 4.9% 2.67 (1.81–3.94) 2.36 (1.58–3.53)
MI at 6 months 3.7% 3.3% 1.02 (0.72–1.44) 0.94 (0.66–1.35) 1.7% 2.99 (1.61–5.55) 2.66 (1.41–5.00)
Death at 1 yr 8.0% 3.6% 1.45 (0.96–2.19) 1.48 (0.97–2.26) 6.2% 2.36 (1.24–4.50) 2.54 (1.30–4.97)
*Only events occurring fromdischarge, or 7 days if hospitalizationwasprolonged,were considered;†Patients in the conservativemedicalmanagement groupwhounderwent PCI or CABGwithin 30dayswere
censored in this end point analysis. Outcomes for the in-hospital PCI and CABG groups are the same as under the “All Patients” analysis in the top rows.
CI confidence interval; HR hazard ratio; other abbreviations as in Table 1.
